Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001 (Second Quarter of Fiscal 2002)
Business Overview: McKesson operates primarily through two segments: Supply Solutions (pharmaceutical and medical-surgical distribution) and Information Solutions (software, services, and hardware). The Supply Solutions segment accounted for approximately 98% of consolidated revenues.
Key Financial Metrics
| Metric (in millions) | Three Months Ended Sep 30, 2001 | Six Months Ended Sep 30, 2001 |
|---|---|---|
| Revenues | $12,159.3 | $23,813.2 |
| Net Income | $79.0 | $184.4 |
| Diluted EPS | $0.27 | $0.63 |
| Operating Income | $147.7 | $306.9 |
| Cash and Equivalents (End of Period) | $286.4 | $286.4 |
| Total Debt (Current + Long-Term) | $1,216.8 | $1,216.8 |
| Net Debt-to-Capital Ratio | 19% | 19% |
Note: Total Debt includes Current portion of long-term debt ($192.8M) and Long-Term Debt ($1,024.0M). Convertible Preferred Securities ($196.0M) are classified separately from debt in the balance sheet but represent a fixed obligation.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 23% year-over-year for the quarter and 22% for the six-month period. Supply Solutions revenues grew 24% (quarter) and 22% (six months), driven by a 25% increase in Pharmaceutical Distribution & Services.
- Profitability: Net income rose 28% for the quarter ($79.0M vs. $61.9M) and 47% for the six months ($184.4M vs. $125.5M). Operating profit increased 20% for the quarter and 21% for the six months.
- Accounting Changes: The company adopted SFAS No. 142 effective April 1, 2001, discontinuing the amortization of goodwill. This change increased reported net income compared to the prior year, which included goodwill amortization charges.
- Cash Flow: Net cash provided by operating activities was $3.6 million for the six months ended September 30, 2001, a significant improvement from a use of $160.5 million in the prior year period. This improvement was driven by a decline in net financial inventory.
Guidance, Outlook, Risks, and Unusual Items
Unusual Items
- Restructuring Charges: The company recorded $21.2 million in restructuring and asset impairment charges for the quarter (including $14.0M exit-related and $6.7M severance) primarily related to closing 23 distribution centers in the medical-surgical business.
- Divestitures: The Information Solutions segment sold two businesses in the six-month period, resulting in a pre-tax loss of $18.4 million but an after-tax gain of $18.4 million due to a $30.0 million tax benefit recognized on a prior year write-down.
- Investment Losses: Corporate segment recorded losses on equity investments ($3.4M for the quarter, $5.7M for six months).
Risks and Contingencies
- Accounting Litigation: Significant ongoing litigation related to accounting improprieties at former subsidiary HBOC. The SEC filed fraud charges against six former HBOC officers in September 2001. The company states it is not feasible to estimate the potential loss, which could be material.
- Market Risk: No material change in exposure to interest rate or foreign currency fluctuations compared to the prior annual report.
Outlook
Management expects to continue back-office reductions in pharmaceutical distribution and workforce reductions in medical-surgical distribution throughout fiscal 2002. The company renewed a $1.075 billion revolving credit facility in October 2001 to support commercial paper borrowings.
Investor Verification Checklist
- Goodwill Amortization Impact: Verify the adjusted net income figures excluding goodwill amortization to compare true operating performance against the prior year.
- Litigation Exposure: Monitor the status of the HBOC accounting litigation and SEC proceedings, as potential settlements could materially impact financial position.
- Working Capital Trends: Review the $538 million increase in inventories to ensure it aligns with new distribution agreements and does not signal future cash flow strain.
- Restructuring Execution: Track the execution of the plan to close 23 distribution centers and the associated cost savings versus the $21.2 million in charges incurred.
- Segment Margins: Analyze the operating margin expansion in Supply Solutions (2.33% for the quarter) to confirm sustainability of productivity improvements.